Insider Transactions in Q3 2023 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,035
+1.01%
|
$10,035
$1.92 P/Share
|
|
Sep 26
2023
|
Richard E Uihlein |
BUY
Exercise of conversion of derivative security
|
Direct |
2,236,204
+4.2%
|
$6,708,612
$3.85 P/Share
|
|
Sep 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,947
+1.12%
|
$10,947
$1.76 P/Share
|
|
Aug 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,010
+1.14%
|
$11,010
$1.75 P/Share
|
|
Aug 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,042
+1.26%
|
$12,042
$1.6 P/Share
|
|
Jul 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,844
+1.35%
|
$12,844
$1.5 P/Share
|
|
Jul 19
2023
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
1,598
+3.17%
|
$1,598
$1.79 P/Share
|
|
Jul 14
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,820
+1.27%
|
$11,820
$1.63 P/Share
|